A call for caution in use of pertussis vaccine effectiveness studies to estimate waning immunity: a Canadian Immunization Research Network Study
Background Vaccine effectiveness (VE) studies provide essential evidence on waning
vaccine-derived immunity, a major threat to pertussis control. We evaluated how study …
vaccine-derived immunity, a major threat to pertussis control. We evaluated how study …
[HTML][HTML] Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations …
C Vandermeulen, H Theeten, N Rathi, S Kuriyakose… - Vaccine, 2015 - Elsevier
Background Regular booster vaccination might be necessary throughout life to protect
against pertussis infection. Nevertheless the duration of protection after booster vaccination …
against pertussis infection. Nevertheless the duration of protection after booster vaccination …
Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults
ME Pichichero, MB Rennels, KM Edwards, MM Blatter… - Jama, 2005 - jamanetwork.com
ContextIncreasing reports of pertussis among US adolescents, adults, and their infant
contacts have stimulated vaccine development for older age groups. ObjectiveTo assess the …
contacts have stimulated vaccine development for older age groups. ObjectiveTo assess the …
[HTML][HTML] Examining the role of different age groups and of vaccination during the 2012 Minnesota pertussis outbreak
There is limited information on the roles of different age groups during pertussis outbreaks.
Little is known about vaccine effectiveness against pertussis infection (both clinically …
Little is known about vaccine effectiveness against pertussis infection (both clinically …
Persistence of antibodies at 5–6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first …
J Langue, N Matisse, P Pacoret, F Undreiner… - Vaccine, 2004 - Elsevier
The main objective of this study was to assess in 5–6-year-old French children (n= 162) the
persistence of antibodies induced by a primary series vaccination (at 2–4 months of age) …
persistence of antibodies induced by a primary series vaccination (at 2–4 months of age) …
Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers
NP Klein, J Bartlett, B Fireman, A Rowhani-Rahbar… - …, 2013 - publications.aap.org
BACKGROUND: During the 1990s, the United States switched from combined diphtheria,
tetanus toxoids, whole-cell pertussis (DTwP) vaccines to combined acellular pertussis …
tetanus toxoids, whole-cell pertussis (DTwP) vaccines to combined acellular pertussis …
[HTML][HTML] Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine
NP Klein, J Bartlett, B Fireman, L Aukes, PO Buck… - Vaccine, 2017 - Elsevier
Background The effectiveness of diphtheria, tetanus, and acellular pertussis (DTaP)
vaccines wanes substantially after the 5 th dose given at ages 4–6 years, but has not been …
vaccines wanes substantially after the 5 th dose given at ages 4–6 years, but has not been …
Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in …
AE Tozzi, A Anemona, D Stat, P Stefanelli… - …, 2001 - publications.aap.org
Objectives. To determine the reactogenicity and immunogenicity of a fourth dose of 2 three-
component acellular pertussis vaccines combined with diphtheria-tetanus-acellular …
component acellular pertussis vaccines combined with diphtheria-tetanus-acellular …
Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States
Abstract Background In the United States, persons≥ 11 years are recommended to receive
one dose of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) …
one dose of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) …
Acellular pertussis vaccine effectiveness over time
OBJECTIVES: To determine pertussis risk by diphtheria-tetanus-acellular pertussis (DTaP)
vaccination status and time since last DTaP dose. METHODS: Children born at Kaiser …
vaccination status and time since last DTaP dose. METHODS: Children born at Kaiser …